Published on March 27, 2020

Many are wondering how to start planning for COVID-19’s impact on clinical trials. Here are some resources that may be helpful:

Regulatory Guidance Documents:


Castor COVID-19 Publications:


COVID-19 Effects on Clinical Trials:


About Castor 

Based in Amsterdam, The Netherlands and New Jersey, US, Castor is an international health-tech company founded by CEO Derk Arts, MD, PhD to leverage machine readable data to increase clinical trial efficiency. Castor’s Electronic Data Capture (EDC) system enables every researcher worldwide to easily capture and integrate medical research data from any source in real-time, including clinicians, patients, devices, wearables, and EHR systems.

In February 2020, Castor joined the global fight against the Coronavirus by making our research data capture system available for free for all COVID-19 research projects. We have developed ready for use eCRFs based on the WHO standard CRFs, to help researchers start their study or registry in less than an hour. As of April 2, Castor is supporting more than 90 COVID-19 studies across 10 countries. Castor also launched a COVID-19 monitoring and research platform to facilitate the rapid deployment of trials to test Coronavirus vaccines and COVID-19 treatments.

Castor encourages all COVID-19 researchers in need of standardized, high quality data to start their studies by registering here, and to visit their online academy to become familiar with the platform. The WHO-defined CRFs can be downloaded here.


Want to join the fight against COVID-19 with Castor ?

Learn More